Nivolumab (nivo) in combination with radiotherapy (RT) ± temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM)

被引：0
|
作者：
Lim, M. [1 ]
Omuro, A. [2 ]
Vlahovic, G. [3 ]
Reardon, D. A. [4 ,5 ]
Sahebjam, S. [6 ]
Cloughesy, T. [7 ]
Baehring, J. [8 ]
Butowski, N. [9 ]
Potter, V. [10 ]
Zwirtes, R. [10 ]
Paliwal, P. [10 ]
Carleton, M. [10 ]
Sampson, J. [3 ]
Brandes, A. A. [11 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Metastat Brain Tumor Ctr, Baltimore, MD USA
[2] Mem Sloan Kettering Canc Ctr, Neurol, 1275 York Ave, New York, NY 10021 USA
[3] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC USA
[4] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Univ S Florida, H Lee Moffitt Canc Ctr, Oncol, Tampa, FL 33682 USA
[7] Univ Calif Los Angeles, Neurol Oncol, Los Angeles, CA USA
[8] Yale Sch Med, Neurol, New Haven, CT USA
[9] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[10] Bristol Myers Squibb Co, Oncol, Princeton, NJ USA
[11] AUSL IRCCS Inst Neurol Sci, Neurol, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3250
引用
收藏
页数：1
相关论文
共 50 条
  • [41] FINAL ANALYSIS OF ACT III: A PHASE II TRIAL OF PF-04948568 (CDX-110) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lai, Rose K.
    Recht, Lawrence D.
    Reardon, David A.
    Paleologos, Nina
    Groves, Morris
    Rosenfeld, Myrna R.
    Meech, Sandra
    Davis, Tom
    Pavlov, Dmitri
    Marshall, Margaret A.
    Sampson, John
    NEURO-ONCOLOGY, 2010, 12 : 76 - 77
  • [42] BEVACIZUMAB, IRINOTECAN AND RADIOTHERAPY VERSUS STANDARD TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: UPDATED RESULTS FROM THE RANDOMIZED MULTICENTER GLARIUS TRIAL
    Herrlinger, Ulrich
    Schaefer, Niklas
    Steinbach, Joachim
    Weyerbrock, Anja
    Hau, Peter
    Goldbrunner, Roland
    Kohnen, Ralf
    Urbach, Horst
    Stummer, Walter
    Glas, Martin
    NEURO-ONCOLOGY, 2013, 15 : 77 - 77
  • [43] Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial
    Herrlinger, U.
    Schaefer, N.
    Steinbach, J. P.
    Weyerbrock, A.
    Hau, P.
    Goldbrunner, R.
    Kohnen, R.
    Urbach, H.
    Stummer, W.
    Glas, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S774 - S774
  • [44] A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Sul, J.
    Panageas, K. S.
    Lassman, A. B.
    Hormigo, A.
    Nolan, C.
    Gavrilovic, I. T.
    Grimm, S. A.
    DeAngelis, L. M.
    Abrey, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Weathers, Shiao-Pei
    Kamiya-Matsuoka, Carlos
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica
    O'Brien, Barbara
    Harrison, Rebecca
    Yung, W. K. Alfred
    Penas-Prado, Marta
    de Groot, John
    NEURO-ONCOLOGY, 2018, 20 : 9 - 10
  • [46] CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Phillips, Heidi
    Sandmann, Thomas
    Li, Congfen
    Cloughesy, Timothy
    Chinot, Olivier L.
    Wick, Wolfgang
    Nishikawa, Ryo
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Lai, Albert
    Moore, Nicola
    Hegde, Priti
    Abrey, Lauren
    Bourgon, Richard
    Garcia, Josep
    Bais, Carlos
    NEURO-ONCOLOGY, 2014, 16
  • [47] Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trial
    Sepulveda, J. M.
    Alonso, M.
    Velilla, G.
    Garcia Grove, C.
    Martinez-Garcia, M.
    Foro, P.
    Garcia Gonzalez, C.
    Muriel Lopez, C.
    Luque, R.
    Luque, N.
    Stradella, A.
    Sabat Viltro, P.
    Navarro Martin, M.
    Rivas Lopez, B.
    Guzman, M.
    Tovar-Ambel, E.
    Velasco, G.
    Sanchez Morillas, R.
    Fuster Salva, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S411 - S411
  • [48] A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Clarke, Jennifer
    Sul, Joohee
    DeAngelis, Lisa
    Lassman, Andrew
    Hormigo, Adilia
    Nolan, Craig
    Gavrilovic, Igor
    Gu, Bin
    Panageas, Kathy
    Abrey, Lauren
    NEURO-ONCOLOGY, 2007, 9 (04) : 530 - 530
  • [49] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
    Piotrowski, Anna
    Puduvalli, Vinay
    Wen, Patrick
    Campian, Jian
    Colman, Howard
    Pearlman, Michael
    Butowski, Nicholas
    Battiste, James
    Glass, Jon
    Cloughesy, Timothy
    Schiff, David
    van den Bent, Martin
    Walbert, Tobias
    Ahluwalia, Manmeet
    Badruddoja, Michael
    Kalra, Amandeep
    Aregawi, Dawit
    Weller, Michael
    Ramakrishnan, Vanitha
    Zhang, Kathy
    Wood, Katie
    Mellinghoff, Ingo
    Shih, Kent
    NEURO-ONCOLOGY, 2019, 21 : 21 - 22
  • [50] NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
    Lassman, A. B.
    Polley, M. C.
    Iwamoto, F. M.
    Sloan, A. E.
    Wang, T. J. C.
    Aldape, K. D.
    Wefel, J. S.
    Gondi, V.
    Gutierrez, A. N.
    Manasawala, M.
    Gilbert, M. R.
    Sulman, E. P.
    Wolchok, J. D.
    Greene, R. M.
    Neil, E. C.
    Lukas, R. V.
    Goldlust, S. A.
    Snuderl, M.
    Dignam, J. J.
    Won, M.
    Movsas, B.
    Mehta, M. P.
    NEURO-ONCOLOGY, 2023, 25
12345